Ryan, you raise valid points, and I believe they will be answered shortly. The fact you point out 'second hand', is further proof of trying to bash the company. Why is this relevant? They all work the same.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
